Protagenic Therapeutics, Inc.\new reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 March
Protagenic Therapeutics, Inc.\new has filed 705 SEC EDGAR filings since 22 Oct 1996

SEC filing history

Showing 351-375 of 448 matching filings.

Per page
25
Current page
15
8-K File 001-12555

FORM 8-K

Filing date
23 Jan 2012
Reporting date
20 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

8-K

Filing date
06 Jan 2012
Reporting date
30 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

FORM 8-K

Filing date
29 Dec 2011
Reporting date
28 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

CURRENT REPORT

Filing date
20 Dec 2011
Reporting date
15 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

8-K

Filing date
06 Dec 2011
Reporting date
30 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

8-K filing

Filing date
02 Dec 2011
Reporting date
01 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

8-K

Filing date
01 Dec 2011
Reporting date
25 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
25 File 001-12555

25

Filing date
14 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

FORM 8-K

Filing date
08 Nov 2011
Reporting date
02 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-175283

FORM 424B3

Filing date
28 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

8-K CURRENT REPORT

Filing date
28 Oct 2011
Reporting date
28 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

8-K

Filing date
28 Oct 2011
Reporting date
27 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-175283

FORM 424B3

Filing date
04 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-175283

EFFECT filing

Filing date
30 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-175283

S-3/A

Filing date
29 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Sep 2011
Reporting date
14 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-12555

8-K

Filing date
15 Sep 2011
Reporting date
14 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-12555

PRELIMININARY PROXY STATEMENT

Filing date
15 Sep 2011
Reporting date
15 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-12555

FORM 10-Q/A

Filing date
07 Sep 2011
Reporting date
30 Jun 2011
Next action
Verify source filing
SC 13D/A File 005-48089

FORM SC 13D/A

Filing date
07 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-175283

S-3/A

Filing date
01 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .